Orchidia Pharma aims to invest EGP 200 mn to establish a new eyedrops factory in Obour City, Production Manager Mohamed Etman told the local press. The company has agreed to import three production lines, including two of whose production capacity is at 30 mn eye drops per year. The EUR 500k third production line is expected to begin producing about 12 mn eye ointments annually next year, Etman said, adding that the company also plans to set up a fourth line in the future.
More from Enterprise
Banque du Caire’s blockbuster IPO holds firm against EGX selloff
The IFC and the EBRD are in for USD 100…
Electricity Ministry studies changing how your electricity bill gets calculated
The plan is still under study, and neither of the…
EGX30 sheds 4.43% in October to post its first back-to-back monthly loss of 2026
The benchmark fell 4.43% and the small caps twice as…
DPI closes Egypt-born fintech fund Nclude at USD 112 mn
The final close adds roughly USD 7 mn to a…